SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-17-245861
Filing Date
2017-08-02
Accepted
2017-08-02 16:31:51
Documents
37
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d419456d10q.htm 10-Q 232923
2 EX-31.1 d419456dex311.htm EX-31.1 6540
3 EX-31.2 d419456dex312.htm EX-31.2 6517
4 EX-32.1 d419456dex321.htm EX-32.1 4555
  Complete submission text file 0001193125-17-245861.txt   1596764

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT oxgn-20170630.xml EX-101.INS 293123
6 XBRL TAXONOMY EXTENSION SCHEMA oxgn-20170630.xsd EX-101.SCH 21024
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE oxgn-20170630_cal.xml EX-101.CAL 25116
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE oxgn-20170630_def.xml EX-101.DEF 37856
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE oxgn-20170630_lab.xml EX-101.LAB 178832
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE oxgn-20170630_pre.xml EX-101.PRE 114116
Mailing Address 701 GATEWAY BLVD. SUITE 210 SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD. SUITE 210 SOUTH SAN FRANCISCO CA 94080 650-635-7000
MATEON THERAPEUTICS INC (Filer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21990 | Film No.: 171000369
SIC: 2836 Biological Products, (No Diagnostic Substances)